资产负债表（Iovance Biotherapeutics Inc）
| 2024年中报 | 2024年一季报 | 2023年年报 | 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 截止日期 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 报表年结日 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 |
| 原始币种 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 流动资产： | ||||||||||
| 现金及现金等价物(元) | 228,678,000.00 | 134,188,000.00 | 114,888,000.00 | 267,720,000.00 | 230,010,000.00 | 543,484,000.00 | 231,731,000.00 | 118,366,000.00 | 108,075,000.00 | 92,360,000.00 |
| 受限制存款及现金流动(元) | 74,000.00 | - | - | - | - | - | - | - | - | - |
| 应收账款及票据(元) | 31,604,000.00 | 234,000.00 | 151,000.00 | - | 33,000.00 | - | - | - | - | - |
| 预付款项及其他应收款流动(元) | 10,183,000.00 | 11,487,000.00 | 17,458,000.00 | 12,017,000.00 | 14,231,000.00 | 11,489,000.00 | 7,271,000.00 | 9,711,000.00 | 7,135,000.00 | 7,779,000.00 |
| 存货(元) | 27,854,000.00 | 17,617,000.00 | 10,372,000.00 | 9,195,000.00 | 9,720,000.00 | - | - | - | - | - |
| 短期投资(元) | 183,864,000.00 | 222,007,000.00 | 164,979,000.00 | 93,654,000.00 | 20,884,000.00 | 82,808,000.00 | 240,114,000.00 | 241,807,000.00 | 316,383,000.00 | 389,829,000.00 |
| 流动资产合计(元) | 482,257,000.00 | 385,533,000.00 | 307,848,000.00 | 382,586,000.00 | 274,878,000.00 | 637,781,000.00 | 479,116,000.00 | 369,884,000.00 | 431,593,000.00 | 489,968,000.00 |
| 非流动资产： | ||||||||||
| 物业、厂房及设备(元) | 110,960,000.00 | 111,789,000.00 | 114,030,000.00 | 113,142,000.00 | 112,549,000.00 | 109,923,000.00 | 105,232,000.00 | 100,746,000.00 | 101,154,000.00 | 102,757,000.00 |
| 受限制存款及现金非流动(元) | 6,356,000.00 | 6,430,000.00 | 66,430,000.00 | 66,430,000.00 | 66,430,000.00 | 6,430,000.00 | 6,430,000.00 | 6,430,000.00 | 6,430,000.00 | 6,084,000.00 |
| 无形资产(元) | 295,299,000.00 | 294,303,000.00 | 229,258,000.00 | 223,610,000.00 | 235,511,000.00 | - | - | - | - | - |
| 长期投资(元) | - | - | - | - | - | - | - | - | - | 27,701,000.00 |
| 非流动资产其他项目(元) | 69,450,000.00 | 71,775,000.00 | 62,785,000.00 | 66,547,000.00 | 67,925,000.00 | 70,633,000.00 | 73,204,000.00 | 68,864,000.00 | 71,701,000.00 | 74,741,000.00 |
| 非流动资产合计(元) | 482,065,000.00 | 484,297,000.00 | 472,503,000.00 | 469,729,000.00 | 482,415,000.00 | 186,986,000.00 | 184,866,000.00 | 176,040,000.00 | 179,285,000.00 | 211,283,000.00 |
| 总资产(元) | 964,322,000.00 | 869,830,000.00 | 780,351,000.00 | 852,315,000.00 | 757,293,000.00 | 824,767,000.00 | 663,982,000.00 | 545,924,000.00 | 610,878,000.00 | 701,251,000.00 |
| 流动负债： | ||||||||||
| 融资租赁负债流动(元) | 11,436,000.00 | 11,078,000.00 | 7,777,000.00 | 10,468,000.00 | 10,866,000.00 | 12,614,000.00 | 12,587,000.00 | 7,171,000.00 | 6,483,000.00 | 7,710,000.00 |
| 应付账款及票据(元) | 20,416,000.00 | 25,700,000.00 | 33,123,000.00 | 19,274,000.00 | 31,157,000.00 | 31,572,000.00 | 26,603,000.00 | 24,255,000.00 | 20,009,000.00 | 20,454,000.00 |
| 其他应付款及应计费用(元) | 61,787,000.00 | 46,436,000.00 | 69,406,000.00 | 61,213,000.00 | 46,620,000.00 | 43,088,000.00 | 52,295,000.00 | 47,819,000.00 | 37,700,000.00 | 48,911,000.00 |
| 流动负债合计(元) | 93,639,000.00 | 83,214,000.00 | 110,306,000.00 | 90,955,000.00 | 88,643,000.00 | 87,274,000.00 | 91,485,000.00 | 79,245,000.00 | 64,192,000.00 | 77,075,000.00 |
| 非流动负债： | ||||||||||
| 融资租赁负债非流动(元) | 69,246,000.00 | 72,291,000.00 | 67,085,000.00 | 68,009,000.00 | 68,844,000.00 | 69,612,000.00 | 71,859,000.00 | 71,943,000.00 | 72,996,000.00 | 71,184,000.00 |
| 应付账款及票据非流动(元) | 1,000,000.00 | 1,000,000.00 | 1,000,000.00 | 1,000,000.00 | 1,000,000.00 | 1,000,000.00 | 1,000,000.00 | 1,000,000.00 | 1,000,000.00 | 1,000,000.00 |
| 递延所得税负债非流动(元) | 31,897,000.00 | 33,301,000.00 | 17,347,000.00 | 18,343,000.00 | 20,237,000.00 | - | - | - | - | - |
| 非流动负债合计(元) | 102,143,000.00 | 106,592,000.00 | 85,432,000.00 | 87,352,000.00 | 90,081,000.00 | 70,612,000.00 | 72,859,000.00 | 72,943,000.00 | 73,996,000.00 | 72,184,000.00 |
| 总负债(元) | 195,782,000.00 | 189,806,000.00 | 195,738,000.00 | 178,307,000.00 | 178,724,000.00 | 157,886,000.00 | 164,344,000.00 | 152,188,000.00 | 138,188,000.00 | 149,259,000.00 |
| 股东权益： | ||||||||||
| 普通股(元) | 12,000.00 | 12,000.00 | 11,000.00 | 11,000.00 | 9,000.00 | 9,000.00 | 8,000.00 | 7,000.00 | 7,000.00 | 7,000.00 |
| 优先股(元) | 3,000.00 | 3,000.00 | 3,000.00 | 3,000.00 | 3,000.00 | 3,000.00 | 3,000.00 | 3,000.00 | 3,000.00 | 3,000.00 |
| 股本溢价(元) | 2,990,451,000.00 | 2,805,244,000.00 | 2,594,448,000.00 | 2,579,087,000.00 | 2,360,468,000.00 | 2,342,703,000.00 | 2,068,867,000.00 | 1,858,783,000.00 | 1,838,778,000.00 | 1,818,377,000.00 |
| 留存收益(元) | -2,222,452,000.00 | -2,125,351,000.00 | -2,012,375,000.00 | -1,895,996,000.00 | -1,782,236,000.00 | -1,675,708,000.00 | -1,568,338,000.00 | -1,463,019,000.00 | -1,363,401,000.00 | -1,264,052,000.00 |
| 累计其他全面收益(元) | 526,000.00 | 116,000.00 | 2,526,000.00 | -9,097,000.00 | 325,000.00 | -126,000.00 | -902,000.00 | -2,038,000.00 | -2,697,000.00 | -2,343,000.00 |
| 归属于母公司股东权益(元) | 768,540,000.00 | 680,024,000.00 | 584,613,000.00 | 674,008,000.00 | 578,569,000.00 | 666,881,000.00 | 499,638,000.00 | 393,736,000.00 | 472,690,000.00 | 551,992,000.00 |
| 股东权益合计(元) | 768,540,000.00 | 680,024,000.00 | 584,613,000.00 | 674,008,000.00 | 578,569,000.00 | 666,881,000.00 | 499,638,000.00 | 393,736,000.00 | 472,690,000.00 | 551,992,000.00 |
| 负债及股东权益合计(元) | 964,322,000.00 | 869,830,000.00 | 780,351,000.00 | 852,315,000.00 | 757,293,000.00 | 824,767,000.00 | 663,982,000.00 | 545,924,000.00 | 610,878,000.00 | 701,251,000.00 |
| 公告日期 | 2024-08-08 | 2024-05-09 | 2024-02-28 | 2023-11-07 | 2023-08-08 | 2023-05-10 | 2023-02-28 | 2022-11-03 | 2022-08-04 | 2022-05-05 |
| 会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 |
| 审计意见 | ||||||||||
| 核数师 |